Traditional non-insulin antihyperglycemic drugs currently accepted for the treating type 2 diabetes mellitus (T2DM) comprise five groups: biguanides, sulfonylureas, meglitinides, glitazones and alpha-glucosidase inhibitors. that protects the cell. The mixed sulfonylurea/metformin therapy unveils additive results on mortality in sufferers with coronary artery disease (CAD). Meglitinides results act like those of sulfonylureas, because of their almost… Continue reading Traditional non-insulin antihyperglycemic drugs currently accepted for the treating type 2
Tag: PR52B
Background: Weight loss reduces body fat and lean mass, but whether
Background: Weight loss reduces body fat and lean mass, but whether these changes are influenced by macronutrient composition of the diet is unclear. 20% fat ( 0.34), or 65% and 35% carbohydrate ( 0.27). Participants lost 2.3 0.2 kg (13.8%) abdominal fat: 1.5 0.2 kg (13.6%) subcutaneous fat and 0.9 0.1 kg (16.1%) visceral fat… Continue reading Background: Weight loss reduces body fat and lean mass, but whether